BioLineRx (NASDAQ:BLRX) Now Covered by StockNews.com
Research analysts at StockNews.com initiated coverage on shares of BioLineRx (NASDAQ:BLRX – Get Free Report) in a note issued to investors on Sunday. The brokerage set a “sell” rating on the biotechnology company’s stock. A number of other research analysts have also recently commented on BLRX. Jones Trading reiterated a “hold” rating on shares of […]
